{"id":6097,"date":"2025-12-23T01:29:17","date_gmt":"2025-12-23T01:29:17","guid":{"rendered":"https:\/\/microvibenews.com\/?p=6097"},"modified":"2025-12-23T01:29:17","modified_gmt":"2025-12-23T01:29:17","slug":"wegovy-pill-approved-by-us-fda-for-weight-loss","status":"publish","type":"post","link":"https:\/\/microvibenews.com\/?p=6097","title":{"rendered":"Wegovy pill approved by US FDA for weight loss"},"content":{"rendered":"<p><\/p>\n<div data-component=\"text-block\">\n<p class=\"sc-9a00e533-0 eZyhnA\">The US Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy, according to maker Novo Nordisk.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">It marks a first in this new era of weight-loss medications with Wegovy being the only so far to gain approval for the pill version of their GLP-1 drug, which has only been available as an injection.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">Wegovy&#8217;s Danish makers Novo Nordisk said the once-daily pill was a &#8220;convenient option&#8221; to the inject-able and would provide the same weight loss as the shot. It comes after Wegovy was approved by the FDA specifically for weight loss.<\/p>\n<p class=\"sc-9a00e533-0 eZyhnA\">Others like Ozempic, which has similar weight-loss effects, were primarily approved for the treatment of Type 2 diabetes.<\/p>\n<\/div>\n<p>#Wegovy #pill #approved #FDA #weight #loss<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The US Food and Drug Administr&hellip; <\/p>\n","protected":false},"author":1,"featured_media":6098,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[242],"tags":[],"_links":{"self":[{"href":"https:\/\/microvibenews.com\/index.php?rest_route=\/wp\/v2\/posts\/6097"}],"collection":[{"href":"https:\/\/microvibenews.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microvibenews.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microvibenews.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microvibenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6097"}],"version-history":[{"count":0,"href":"https:\/\/microvibenews.com\/index.php?rest_route=\/wp\/v2\/posts\/6097\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microvibenews.com\/index.php?rest_route=\/wp\/v2\/media\/6098"}],"wp:attachment":[{"href":"https:\/\/microvibenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microvibenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microvibenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}